Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Is clarinex off patent?Are there specific stretches to avoid while on lipitor?When did risperdal constas patent expire published article?Combivent inhaler hfc 152a patents?Dabrafenib and trametinib cost?
See the DrugPatentWatch profile for Extavia
Extavia is a brand name for interferon beta-1b, a medicine used in the treatment of multiple sclerosis (MS). [1]
Extavia is prescribed for MS to reduce the frequency of relapses and help manage disease activity in appropriate patients. [1]
Extavia contains interferon beta-1b, which helps regulate immune activity involved in MS. [1]
Extavia is administered as an injection. [1]
Common patient concerns with interferon-based MS therapies include flu-like symptoms and injection-site reactions; specific side effects and frequency depend on the prescribing information. [1]
Extavia is a branded product available from pharmaceutical manufacturers; the specific manufacturer and distributor can vary by country and supply. [1] ---
[1] https://www.extavia.com/ (product information site)
Other Questions About Extavia :